cdmo.directory
← Back to posts

CDMO Daily News — November 21, 2026

By BioBM ·

At a glance

Related topics: Manufacturing capacity

South Korea's New CDMO Special Act Enhances Biologics Manufacturing Capacity

Operational Impact

LOTTE Biologics' early completion of its Songdo facility adds significant capacity, supporting the growing demand for biologics manufacturing in Korea.

Source: PharmaSource RSS

References

  1. PharmaSource RSS — South Korea's New CDMO Special Act Enhances Biologics Manufacturing Capacity

Deep dive by email

Get the next CDMO deep dive by email. One message when it publishes. No daily digest.

Markdown mirror: /posts/daily-news-2026-11-21-cdmo.md